Egnyte Creates Egnyte for Life Sciences Platform


Egnyte has announced Egnyte for Life Sciences, a purpose-built platform to serve those advancing the science of health. Egnyte’s solution aims to help biotech, medical device, and diagnostics companies accomplish three outcomes: meeting regulatory compliance standards, expedite data sharing and collaboration, and secure essential intellectual property.

The platform provides document management capabilities to facilitate intra- and inter-institutional collaboration while maintaining compliance with FDA 21 CFR Part 11 directives.

Egnyte is also announcing the formation of a Life Sciences Advisory Board to shape its offerings and go-to-market strategy in the industry.

Read the full release, here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.